Literature DB >> 25661899

Dissemination of trauma-focused cognitive-behavioral therapy: a follow-up study of practitioners' knowledge and implementation.

Jane D Woody1, Debra K Anderson, Henry J D'Souza, Beth Baxter, Jill Schubauer.   

Abstract

In this follow-up study the authors examine the impact of two projects that provided volunteer practitioners with extensive training in trauma-focused cognitive-behavioral therapy (TF-CBT). The objective was to gain empirical data about clinicians' knowledge of the model and implementation 10-15 months after training. The 30 respondents achieved a mean knowledge score of 80% for eight hypothetical clinical vignettes, positive results for clients' attendance at initial appointments, parental involvement, and low dropout rates, but somewhat lower use of child and parent trauma work. Use of selected TF-CBT components was strong, with lowest rates for child and parent trauma narrative and modifying cognitions. Intentions to use the model were high. Implications and recommendations are discussed.

Entities:  

Keywords:  Empirically supported treatment; dissemination; implementation; knowledge; trauma-focused cognitive behavior therapy

Mesh:

Year:  2015        PMID: 25661899     DOI: 10.1080/15433714.2013.849217

Source DB:  PubMed          Journal:  J Evid Inf Soc Work        ISSN: 2376-1407


  2 in total

1.  Lessons learned while building a trauma-informed public behavioral health system in the City of Philadelphia.

Authors:  Rinad S Beidas; Danielle R Adams; Hilary E Kratz; Kamilah Jackson; Steven Berkowitz; Arturo Zinny; Lauren Pilar Cliggitt; Kathryn L DeWitt; Laura Skriner; Arthur Evans
Journal:  Eval Program Plann       Date:  2016-07-27

2.  Brief Behavioral Therapy for Pediatric Anxiety and Depression in Primary Care: A Follow-up.

Authors:  David A Brent; Giovanna Porta; Michelle S Rozenman; Araceli Gonzalez; Karen T G Schwartz; Frances L Lynch; John F Dickerson; Satish Iyengar; V Robin Weersing
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-07-03       Impact factor: 8.829

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.